Back to Newsroom

Catalyst Pharmaceuticals Appoints Paul J. Merrigan as Chief Commercial Officer

CORAL GABLES, Fla., Aug. 17, 2015 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced the appointment of Paul J. Merrigan as Chief Commercial Officer.  Mr. Merrigan will be responsible for leading Catalyst’s marketing, sales and commercial operations. He replacesRichard Daly, who served as interim Chief Commercial Officer during the search. Mr. Daly will continue in his role as a member of the board of directors.

Click here to read more